Starling Oncology, Inc. Goodwill, Fair Value Disclosure
Starling Oncology, Inc. (DFPH) had Goodwill, Fair Value Disclosure of $21.42 million as of 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:GoodwillFairValueDisclosure · last filed 2023-03-16
- 2022-12-31: Goodwill, Fair Value Disclosure $21.42M.
| Period end | Goodwill, Fair Value Disclosure |
|---|---|
| 2022-12-31 | $21.42M 10-K · filed 2023-03-16 |